Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

BBHvsIDEV

VanEck Biotech ETF against iShares Core MSCI International Developed Markets ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
BBH 132IDEV 110Nov 25Nov 26GROWTH OF $100
Head to head
BBHIDEV
Expense ratio0.35%0.040%
Assets$535M$34B
Net flow, 1 month+$25M+$587M
Net flow, 1 year+$39M+$8B
Return, YTD+31.5%+7.2%
Return, 1 year——
Avg daily volume17K2.2M
Holdings252310
ListedNov 23, 1999Mar 21, 2017
Options marketYesYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.